Related Experiment Video

Updated: Nov 6, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

956

Surgical Treatment of Ischemic Dilative Cardiomyopathy by Ventricular Restoration

Guglielmo Stefanelli1, Clorinda Labia1, Marco Meli1

  • 1Department of Cardiac Surgery, Hesperia Hospital, Modena, Italy.

Surgical Technology International
|May 10, 2021
PubMed

Insights

Surgical ventricular restoration (SVR) reshapes the left ventricle in heart failure patients, offering an alternative to heart transplant. This procedure aims to improve survival and quality of life for those with post-ischemic dilative cardiomyopathy.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Regenerative Medicine

Background:

  • Symptomatic post-ischemic dilative cardiomyopathy of the left ventricle often necessitates interventions beyond medication.
  • Current treatments aim to prolong survival, enhance quality of life, and reduce heart failure re-hospitalizations.

Purpose of the Study:

  • To provide an overview of surgical ventricular restoration (SVR) for treating dilative ischemic cardiomyopathy.
  • To discuss surgical options, operative details, and indications for SVR.
  • To propose a novel one-step cell therapy protocol during SVR for heart failure patients.

Main Methods:

  • Review of surgical ventricular restoration techniques for left ventricular reshaping.
  • Discussion of indications and operative considerations for SVR.
  • Presentation of a protocol for concurrent cell therapy during SVR.

Main Results:

  • Surgical ventricular restoration is a viable treatment option for select heart failure patients, serving as an alternative to heart transplantation.
  • The procedure aims to improve long-term outcomes, including survival and quality of life.
  • Cell therapy integrated with SVR presents an innovative approach to managing heart failure.

Conclusions:

  • Surgical ventricular restoration is a valuable therapeutic tool for patients with dilative ischemic cardiomyopathy.
  • Careful patient selection and surgical technique are crucial for successful outcomes.
  • The integration of cell therapy with SVR holds promise for advancing heart failure treatment.

More Related Videos

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.4K
Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

8.4K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
99
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
117
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
158
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
116
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
45